Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03789240
Title Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

follicular lymphoma

Therapies

Copanlisib + Rituximab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.